# Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance), Division 4: Lapse or withdrawal of certificates


For the purposes of Article 14—
(a)where a NI authorisation in respect of a product becomes a former NI authorisation and a GB authorisation for the same product becomes a transitioned-UK authorisation, a certificate based upon the NI and GB authorisations before 1 January 2025 shall not lapse;
(b)any reference to the withdrawal of a NI authorisation under Article 14 includes a case where a NI authorisation becomes a former NI authorisation, and in such a case, the authorisation shall be treated as being withdrawn in relation to the territory of Northern Ireland on 1 January 2025.

---
Source: https://www.legislation.gov.uk/eur/2009/469/annex/III/division/4. (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-469/annex-III/division-4.
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.